Lv42
710 积分 2025-01-06 加入
Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study
5小时前
已关闭
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
12天前
已完结
Ryzneuta for Prevention of Febrile Neutropenia
25天前
已关闭
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study
1个月前
已完结
Efbemalenograstim Alfa: First Approval
2个月前
已完结
Comparison of a dual inhibitor of VEGF and FGF signaling, BMS-582664, to the activity of bevacizumab, an inhibitor exclusively of VEGF signaling, in xenograft models of colon carcinoma
2个月前
已关闭
Diagnosis and Treatment of Metastatic Colorectal Cancer
2个月前
已完结
Efbemalenograstim Alfa: First Approval
2个月前
已完结
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
2个月前
已完结
Metabolism and Distribution of Novel Tumor Targeting Drugs In Vivo
2个月前
已完结
皖公网安备34019202002308
